Literature DB >> 6979311

Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.

M F Lampe, B J Allan, B H Minshew, J C Sherris.   

Abstract

Mutants with enhanced beta-lactam resistance were selected from strains of Enterobacter cloacae and E. aerogenes by using three antibiotics. High-level beta-lactamase-producing mutants had similar degrees of increased resistance, enzyme substrate profiles, and isoelectric (pI) values irrespective of the selective agent. Reverse mutants from a resistant E. cloacae mutant regained the susceptibility pattern originally exhibited by the wild type, or were of enhanced susceptibility, and no longer expressed increased beta-lactamase production. beta-Lactamases of the mutants were similar in pI values to the wild-type enzyme. The increased resistance of the mutants therefore appeared to be accounted for by increased beta-lactamase production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979311      PMCID: PMC181960          DOI: 10.1128/AAC.21.4.655

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Beta-lactamase assays.

Authors:  G W Ross; C H O'Callaghan
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

Authors:  C M Findell; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

5.  Inducible beta-lactamase in Enterobacter.

Authors:  T D Hennessey
Journal:  J Gen Microbiol       Date:  1967-11

6.  Spontaneous mutant with loss of beta-lactamase in Aerobacter cloacae.

Authors:  M Goldner; D G Glass; P C Fleming
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

7.  Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins.

Authors:  C H O'Callaghan; P W Muggleton; G W Ross
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

Review 8.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

View more
  20 in total

1.  Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.

Authors:  J C Fung-Tomc; E Gradelski; E Huczko; T J Dougherty; R E Kessler; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Purification of a class C A-type beta-lactamase from a derepressed strain of Enterobacter cloacae. Comparison of the wild-type and mutant enzyme with those from strains P99, 208 and GN7471.

Authors:  M N Graham; T J Mantle
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.

Authors:  B Marchou; F Bellido; R Charnas; C Lucain; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 4.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

5.  Selection of resistant mutants of Citrobacter freundii by second and third-generation cephalosporins and imipenem.

Authors:  A M del Rosario Valencia; A Vuye; J Pijck
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

6.  Rapid antimicrobial susceptibility testing of isolates from blood cultures by direct inoculation and early reading of disk diffusion tests.

Authors:  M B Coyle; L A McGonagle; J J Plorde; C R Clausen; F D Schoenknecht
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

7.  Antibacterial activity of cefoperazone alone and in combination against cephalosporinase-producing Enterobacter cloacae.

Authors:  S Minami; N Matsubara; A Yotsuji; Y Watanabe; T Yasuda; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

8.  Third generation cephalosporins--a panacea for intensive care patients?

Authors:  F A Waldvogel
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

9.  Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

Authors:  T D Gootz; D B Jackson; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

10.  Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.